	Ebitda		日
Acadia Pharmaceuticals	USD -1.62M	21.94M	2026-03
Adma Biologics	USD 61.07M	12.52M	2026-03
ALKERMES	USD 139.22M	58.96M	2026-06
Alterity Therapeutics Limited	AUD -7.72M	2.99M	2023-06
AstraZeneca	USD 5.16B	510M	2026-06
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Bristol-Myers Squibb	USD 4.24B	1.37B	2026-03
Cipla	INR 14.03B	4.48B	2026-06
Clal Biotechnology	ILS -5.3M	2.09M	2022-12
Compugen	USD -9.02M	1.12M	2026-03
CSL	USD 3.13B	1.17B	2025-12
Eli Lilly	USD 10.29B	1.86B	2026-03
GlaxoSmithKline	GBP 3.51B	734M	2026-06
Grifols	EUR 482.04M	7.04M	2025-09
Halozyme Therapeutics	USD 328.81M	109.24M	2026-06
Ionis Pharmaceuticals	USD -64.53M	135.49M	2026-03
J&J	USD 8.27B	1.08B	2026-03
Merck	USD -1.54B	7.84B	2026-03
Minerva Neurosciences	USD -4.36M	1.71M	2024-09
Neurocrine Biosciences	USD 193.3M	25.1M	2026-03
Novartis	USD 6.48B	1.19B	2026-06
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 6.01B	18M	2026-06
Roche Holding	CHF 13.43B	744M	2026-06
Sanofi	EUR 3.69B	375M	2026-06
Takeda	JPY 364.46B	214.21B	2026-06
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12